The storied success of sildenafil has undeniably transformed the drug landscape. However, investing in companies heavily focused on biosimilars and the diminishing patent protection surrounding this https://bookmarkbirth.com/story22006648/the-blue-pill-and-drugmakers-a-uncertain-venture